[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ⑨ | Interview with Dr. Konika Patel Schallen, Medical Director, Candela
Candela, a global leader in energy-based aesthetic devices with a comprehensive portfolio including GentleMax Pro Plus, PicoWay, and Vbeam, unveiled three new platforms at IMCAS World Congress 2026: the next-generation vascular laser 'Vbeam Pro,' the RF microneedling workstation 'Matrix,' and the skin purification system 'Glacē'—signaling a paradigm shift toward skin health-centered aesthetics. Founded in 1970 with over five decades of innovation, Candela distributes its products in more than 100 countries, and its Vbeam remains the only FDA-cleared vascular laser for pediatric vascular malformations, deployed in over 700 children's hospitals worldwide. Speaking at the Candela booth in Paris, Dr. Konika Patel Schallen, Medical Director and SVP of Global Clinical Operations, noted that "2026 marks a turning point in the science of anti-aging," adding that "Korea is a hugely influential market on the global stage, and it is essential that its growth continues to be driven by science rather than trends."
#MedicalAestheticNews #IMCAS2026 #Candela #VbeamPro #Matrix #Glacē #GentleMaxProPlus
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11226

Comments
Post a Comment